Tapewire

NYSE · USD

ZBH

ZIMMER BIOMET HOLDINGS, INC.

Export transactions ↓
Tapewire entity
3278
SEC CIK
0001136869
Parsed reports
830

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202601
Mar 202601
Apr 202600
May 202602
Jun 202600
Jul 202600
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 30, 2024 Filed Jul 2, 2024 20:52 UTC GrantPhantom Stock Units · Derivative 553.097 $0.00 Strike: $108.48 $0.00
Disclosure

SEC source: 0001062993-24-013336 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,146.509

Underlying: Common Stock · 553.097 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 20:51 UTC GrantPhantom Stock Units · Derivative 299.594 $0.00 Strike: $108.48 $0.00
Disclosure

SEC source: 0001062993-24-013333 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,586.221

Underlying: Common Stock · 299.594 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 20:50 UTC GrantPhantom Stock Units · Derivative 311.117 $0.00 Strike: $108.48 $0.00
Disclosure

SEC source: 0001062993-24-013332 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,477.657

Underlying: Common Stock · 311.117 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 20:49 UTC GrantPhantom Stock Units · Derivative 126.751 $0.00 Strike: $108.48 $0.00
Disclosure

SEC source: 0001062993-24-013329 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,854.171

Underlying: Common Stock · 126.751 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 20:49 UTC GrantPhantom Stock Units · Derivative 253.503 $0.00 Strike: $108.48 $0.00
Disclosure

SEC source: 0001062993-24-013328 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,036.904

Underlying: Common Stock · 253.503 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 20:48 UTC GrantPhantom Stock Units · Derivative 253.503 $0.00 Strike: $108.48 $0.00
Disclosure

SEC source: 0001062993-24-013325 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,486.617

Underlying: Common Stock · 253.503 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 20:47 UTC GrantPhantom Stock Units · Derivative 126.751 $0.00 Strike: $108.48 $0.00
Disclosure

SEC source: 0001062993-24-013323 · form4.xml · derivative · entry 1

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 847.055

Underlying: Common Stock · 126.751 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 20:46 UTC GrantPhantom Stock Units · Derivative 144.035 $0.00 Strike: $108.48 $0.00
Disclosure

SEC source: 0001062993-24-013321 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,772.565

Underlying: Common Stock · 144.035 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 01, 2024 Filed Jun 4, 2024 20:20 UTC
Stellato Paul AVP, Controller & CAO
Exercise / conversionRestricted Stock Units · Derivative 627 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-011816 · form4.xml · derivative · entry 3

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 626

Underlying: Common Stock · 627 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: One-third of the RSUs vested on June 1, 2023, and one-third vested on June 1, 2024. The remaining RSUs vest on June 1, 2025.

F3 · derivative.expiration_date: One-third of the RSUs vested on June 1, 2023, and one-third vested on June 1, 2024. The remaining RSUs vest on June 1, 2025.

Read SEC document
June 01, 2024 Filed Jun 4, 2024 20:20 UTC
Stellato Paul AVP, Controller & CAO
Tax withholdingCommon Stock 197 $114.47 $22,550.59
Disclosure

SEC source: 0001062993-24-011816 · form4.xml · nonDerivative · entry 2

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,382

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
June 01, 2024 Filed Jun 4, 2024 20:20 UTC
Stellato Paul AVP, Controller & CAO
Exercise / conversionCommon Stock 627 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-011816 · form4.xml · nonDerivative · entry 1

Stellato Paul A · CIK 0001714585 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,579

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:21 UTC
Yi SangGroup President, Asia Pacific
SaleCommon Stock 12,857 $114.69 $1,474,582.19
Disclosure

SEC source: 0001062993-24-011819 · form4.xml · nonDerivative · entry 1

Yi Sang · CIK 0001635943 · Group President, Asia Pacific

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,322

F1 · price: Reflects the weighted average price of 12,857 common shares sold by the reporting person in multiple transactions on May 31, 2024 with sale prices ranging from $114.64 to 114.79 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:09 UTC GrantRestricted Stock Units · Derivative 1,068.991 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-010233 · form4.xml · derivative · entry 2

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,068.991

Underlying: Common Stock · 1,068.991 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F4 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the late of (1) the reporting person's termination of serves as a Director or (2) the date that is three years after the grant date.

F4 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the late of (1) the reporting person's termination of serves as a Director or (2) the date that is three years after the grant date.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:09 UTC GrantPhantom Stock Units · Derivative 616.726 $0.00 Strike: $121.61 $0.00
Disclosure

SEC source: 0001062993-24-010233 · form4.xml · derivative · entry 1

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 720.304

Underlying: Common Stock · 616.726 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:08 UTC GrantRestricted Stock Units · Derivative 1,068.991 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-010231 · form4.xml · derivative · entry 2

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,952.928

Underlying: Common Stock · 1,068.991 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:08 UTC GrantPhantom Stock Units · Derivative 616.726 $0.00 Strike: $121.61 $0.00
Disclosure

SEC source: 0001062993-24-010231 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,628.53

Underlying: Common Stock · 616.726 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 5.737 phantom stock units accrued on April 30, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:08 UTC GrantRestricted Stock Units · Derivative 0 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-010232 · form4.xml · derivative · entry 2

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,549.937

Underlying: Common Stock · 0 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:08 UTC GrantPhantom Stock Units · Derivative 0 $0.00 Strike: $121.61 $0.00
Disclosure

SEC source: 0001062993-24-010232 · form4.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,239.749

Underlying: Common Stock · 0 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 23.851 phantom stock units accrued on April 30, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:04 UTC GrantRestricted Stock Units · Derivative 1,068.991 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-010227 · form4.xml · derivative · entry 2

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,173.928

Underlying: Common Stock · 1,068.991 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:04 UTC GrantPhantom Stock Units · Derivative 616.726 $0.00 Strike: $121.61 $0.00
Disclosure

SEC source: 0001062993-24-010227 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,727.42

Underlying: Common Stock · 616.726 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 9.925 phantom stock units accrued on April 30, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:04 UTC GrantRestricted Stock Units · Derivative 1,068.991 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-010226 · form4.xml · derivative · entry 2

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,173.928

Underlying: Common Stock · 1,068.991 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:04 UTC GrantPhantom Stock Units · Derivative 616.726 $0.00 Strike: $121.61 $0.00
Disclosure

SEC source: 0001062993-24-010226 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,233.114

Underlying: Common Stock · 616.726 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 14.686 phantom stock units accrued on April 30, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:01 UTC GrantRestricted Stock Units · Derivative 1,068.991 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-010221 · form4.xml · derivative · entry 2

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,997.928

Underlying: Common Stock · 1,068.991 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:01 UTC GrantPhantom Stock Units · Derivative 616.726 $0.00 Strike: $121.61 $0.00
Disclosure

SEC source: 0001062993-24-010221 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,166.54

Underlying: Common Stock · 616.726 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 54.104 phantom stock units accrued on April 30, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:00 UTC GrantRestricted Stock Units · Derivative 1,068.991 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-010218 · form4.xml · derivative · entry 2

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,577.928

Underlying: Common Stock · 1,068.991 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2024 Filed May 14, 2024 21:00 UTC GrantPhantom Stock Units · Derivative 616.726 $0.00 Strike: $121.61 $0.00
Disclosure

SEC source: 0001062993-24-010218 · form4.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,501.129

Underlying: Common Stock · 616.726 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 35.416 phantom stock units accrued on January 31, 2024 and 37.432 phantom stock units accrued on April 30, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:56 UTC GrantRestricted Stock Units · Derivative 1,068.991 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-010211 · form4.xml · derivative · entry 2

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,831.928

Underlying: Common Stock · 1,068.991 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:56 UTC GrantPhantom Stock Units · Derivative 616.726 $0.00 Strike: $121.61 $0.00
Disclosure

SEC source: 0001062993-24-010211 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,286.627

Underlying: Common Stock · 616.726 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 26.611 phantom stock units accrued on April 30, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:54 UTC GrantRestricted Stock Units · Derivative 1,068.991 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-010207 · form4.xml · derivative · entry 2

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,683.928

Underlying: Common Stock · 1,068.991 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:54 UTC GrantPhantom Stock Units · Derivative 616.726 $0.00 Strike: $121.61 $0.00
Disclosure

SEC source: 0001062993-24-010207 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,593.412

Underlying: Common Stock · 616.726 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 36.719 phantom stock units accrued on April 30, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:54 UTC GrantRestricted Stock Units · Derivative 1,068.991 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-010206 · form4.xml · derivative · entry 2

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,452.928

Underlying: Common Stock · 1,068.991 shares

Expires not disclosed

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:54 UTC GrantPhantom Stock Units · Derivative 616.726 $0.00 Strike: $121.61 $0.00
Disclosure

SEC source: 0001062993-24-010206 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,783.401

Underlying: Common Stock · 616.726 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 63.349 phantom stock units accrued on April 30, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 20:35 UTC
Winkler LoriSVP and CHRO
Exercise / conversionRestricted Stock Units · Derivative 772 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-007949 · form4.xml · derivative · entry 3

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 772 shares

Expires 2024-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of ZimVie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 20:35 UTC
Winkler LoriSVP and CHRO
Tax withholdingCommon Stock 215 $130.65 $28,089.75
Disclosure

SEC source: 0001062993-24-007949 · form4.xml · nonDerivative · entry 2

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,336

F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 20:35 UTC
Winkler LoriSVP and CHRO
Exercise / conversionCommon Stock 772 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-007949 · form4.xml · nonDerivative · entry 1

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,551

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of ZimVie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.

Read SEC document
March 31, 2024 Filed Apr 2, 2024 21:25 UTC GrantPhantom Stock Units · Derivative 207.156 $0.00 Strike: $132.75 $0.00
Disclosure

SEC source: 0001062993-24-007770 · form4.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,215.898

Underlying: Common Stock · 207.156 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 22.447 phantom stock units accrued on January 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2024 Filed Apr 2, 2024 21:25 UTC GrantPhantom Stock Units · Derivative 207.156 $0.00 Strike: $132.75 $0.00
Disclosure

SEC source: 0001062993-24-007769 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,601.702

Underlying: Common Stock · 207.156 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 13.657 phantom stock units accrued on January 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2024 Filed Apr 2, 2024 21:24 UTC GrantPhantom Stock Units · Derivative 207.156 $0.00 Strike: $132.75 $0.00
Disclosure

SEC source: 0001062993-24-007766 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,103.326

Underlying: Common Stock · 207.156 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 60.334 phantom stock units accrued on January 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2024 Filed Apr 2, 2024 21:24 UTC GrantPhantom Stock Units · Derivative 103.578 $0.00 Strike: $132.75 $0.00
Disclosure

SEC source: 0001062993-24-007767 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,100.769

Underlying: Common Stock · 103.578 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 9.305 phantom stock units accrued on January 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2024 Filed Apr 2, 2024 21:23 UTC GrantPhantom Stock Units · Derivative 244.821 $0.00 Strike: $132.75 $0.00
Disclosure

SEC source: 0001062993-24-007765 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,643.29

Underlying: Common Stock · 244.821 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 25.017 phantom stock units accrued on January 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2024 Filed Apr 2, 2024 21:23 UTC GrantPhantom Stock Units · Derivative 117.702 $0.00 Strike: $132.75 $0.00
Disclosure

SEC source: 0001062993-24-007764 · form4.xml · derivative · entry 1

Kolli Sreelakshmi · CIK 0001689392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,006.067

Underlying: Common Stock · 117.702 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 5.258 phantom stock units accrued on January 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2024 Filed Apr 2, 2024 21:22 UTC GrantPhantom Stock Units · Derivative 451.977 $0.00 Strike: $132.75 $0.00
Disclosure

SEC source: 0001062993-24-007762 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,939.967

Underlying: Common Stock · 451.977 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 34.283 phantom stock units accrued on January 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2024 Filed Apr 2, 2024 21:21 UTC GrantPhantom Stock Units · Derivative 254.237 $0.00 Strike: $132.75 $0.00
Disclosure

SEC source: 0001062993-24-007761 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,495.71

Underlying: Common Stock · 254.237 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 51.369 phantom stock units accrued on January 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
March 31, 2024 Filed Apr 2, 2024 21:20 UTC GrantPhantom Stock Units · Derivative 103.578 $0.00 Strike: $132.75 $0.00
Disclosure

SEC source: 0001062993-24-007760 · form4.xml · derivative · entry 1

Shapiro Louis · CIK 0001999146 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103.578

Underlying: Common Stock · 103.578 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
March 07, 2024 Filed Mar 8, 2024 22:03 UTC
Yi SangGroup President, Asia Pacific
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,705 $0.00 Strike: $91.53 $0.00
Disclosure

SEC source: 0001062993-24-006020 · form4.xml · derivative · entry 5

Yi Sang · CIK 0001635943 · Group President, Asia Pacific

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,705 shares

Expires 2024-03-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully vested.

Read SEC document
March 07, 2024 Filed Mar 8, 2024 22:03 UTC
Yi SangGroup President, Asia Pacific
SaleCommon Stock 1,705 $126.86 $216,296.30
Disclosure

SEC source: 0001062993-24-006020 · form4.xml · nonDerivative · entry 3

Yi Sang · CIK 0001635943 · Group President, Asia Pacific

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,179

Read SEC document
March 07, 2024 Filed Mar 8, 2024 22:03 UTC
Yi SangGroup President, Asia Pacific
Exercise / conversionCommon Stock 1,705 $91.53 $156,058.65
Disclosure

SEC source: 0001062993-24-006020 · form4.xml · nonDerivative · entry 2

Yi Sang · CIK 0001635943 · Group President, Asia Pacific

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,884

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 06, 2024 Filed Mar 8, 2024 22:05 UTC
Winkler LoriSVP and CHRO
Exercise / conversionRestricted Stock Units · Derivative 1,757 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-006029 · form4.xml · derivative · entry 3

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,513

Underlying: Common Stock · 1,757 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026.

F3 · derivative.expiration_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026.

Read SEC document
March 06, 2024 Filed Mar 8, 2024 22:05 UTC
Winkler LoriSVP and CHRO
Tax withholdingCommon Stock 428 $125.82 $53,850.96
Disclosure

SEC source: 0001062993-24-006029 · form4.xml · nonDerivative · entry 2

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,779

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
March 06, 2024 Filed Mar 8, 2024 22:05 UTC
Winkler LoriSVP and CHRO
Exercise / conversionCommon Stock 1,757 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-006029 · form4.xml · nonDerivative · entry 1

Winkler Lori · CIK 0001852191 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,207

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.